Evidence map›Paper›PMID 38915053›Full record

ArticleJournal of translational medicine2024

circSORBS1 inhibits lung cancer progression by sponging miR-6779-5p and directly binding RUFY3 mRNA.

Haotian Xu, Yue Zheng, Jiaxi Wu, Ruirui Zhang, Qingyun Zhao, Sixian Chen, Wenyi Peng, Dunyu Cai, Yihong Gao, Xingcai Chen and 4 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Roles and Applications of Circular RNA in Virus Infection.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Haotian Xu *School of Public Health, Guangxi Medical University, Nanning, 530021, China.
Yue Zheng *School of Public Health, Guangxi Medical University, Nanning, 530021, China.
Jiaxi Wu *School of Public Health, Guangxi Medical University, Nanning, 530021, China.
Ruirui ZhangSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Qingyun ZhaoSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Sixian ChenSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Wenyi PengSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Dunyu CaiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Yihong GaoSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Xingcai ChenSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Deqing LiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Shengyi YuanSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Gang LiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China. ligang@gxmu.edu.cn.
Aruo NanSchool of Public Health, Guangxi Medical University, Nanning, 530021, China. nanaruo@163.com.

Funding

Guangxi Science and Natural Science Foundation of Guangxi 2023GXNSFFA026006Guangxi Science and Technology Base and Talent Special Project AD22080055National Natural Science Foundation of China NSFC82260652
6 · The paper itself

Abstract

Lung cancer is the primary cause of cancer-related death worldwide, and its global incidence and mortality rates remain high. The differential expression of circular RNAs (circRNAs) can affect the development of cancer, but the mechanisms by which circRNAs regulate lung cancer progression remain unclear. In this study, we identified circSORBS1, a circRNA that has not been previously described in lung cancer and is significantly underexpressed in lung cancer tissues, blood and cell lines, and the low expression of circSORBS1 correlated with tumour grade and prognosis. In vitro and in vivo functional experiments revealed that circSORBS1 overexpression inhibited cell proliferation and migration while enhancing apoptosis. Mechanistically, circSORBS1 acts as a sponge for miR-6779-5p, indirectly inhibiting RUFY3 mRNA degradation. Simultaneously, it binds to RUFY3 mRNA to enhance its stability. This dual regulatory mechanism leads to an increase in RUFY3 protein levels, which ultimately activates the YWHAE/BAD/BCL2 apoptotic signalling pathway and suppresses lung cancer progression. Our findings not only increase the knowledge about the regulatory pattern of circRNA expression but also provide new insights into the mechanisms by which circRNAs regulate lung cancer development.

Indexed as

ApoptosisCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticLung NeoplasmsMicroRNAsRNA, CircularRNA, MessengerAnimalsBase SequenceCell Line, TumorCell MovementCytoskeletal ProteinsFemaleHumansMaleCytoskeletal ProteinsMicrofilament ProteinsMicroRNAsRNA, CircularRNA, MessengerRUFY3 protein, humanSORBS1 protein, humancircSORBS1Lung cancermiR-6779-5pRUFY3

Identifiers

PMID38915053
PMCPMC11197270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.